Background: Retinopathy of prematurity is one of the leading causes of childhood blindness worldwide, with vessel growth cessation and vessel loss in phase I followed by neovascularization in phase II. Ischaemia contributes to its pathogenesis, and lutein protects against ischaemia-induced retinal damages. We aimed to investigate the effects of lutein on a murine model of oxygen-induced retinopathy.
INTRODUCTION
Retinopathy of prematurity (ROP), with vessel growth cessation and vessel loss followed by vision-threatening pathological vessel proliferation, 1 is a common eye disorder in preterm babies. With advances in neonatal care and increased survival rate of extremely smaller preterm infants, the incidence of ROP increases. 2 The pathogenesis of ROP is multi-factorial, and the main risk factors are a gestational age of 32 weeks or less, low birth weight and oxygen use. 1, 3 Relative hypoxia develops after oxygen therapy, triggering pathologic neovessel growth in response to increased metabolic demand of developing retina. Therefore, ischaemia plays a crucial role in the development of ROP. 2 Lutein is a member of xanthophyll family of carotenoids and contained in dark green vegetables, such as spinach and kale. [4] [5] [6] [7] Lutein protects against retinal ischaemia/reperfusion injury in vivo and directly protects retinal neuronal cells from H 2 O 2 -induced oxidative stress and cobalt chloride (CoCl 2 )-induced hypoxia in vitro. 5, 8 We hypothesized that lutein might protect against ischaemia-induced ROP.
Three recent randomized controlled trial studies of lutein in ROP patients reported that lutein appeared to be ineffective in preventing proliferative ROP in preterm infants. [9] [10] [11] However, a decreasing trend of the progression rate from early ROP stages to threshold ROP (defined as beyond which there is 50% likelihood of the incidence of unfavourable outcomes) was shown. 9, 12 Therefore, the effect of lutein in ROP needs to be further assessed. In addition, as preterm infants are fragile with incomplete development, the efficacy of lutein treatment in ROP needs to be evaluated thoroughly in preclinical animal models. In this study, mouse oxygen-induced retinopathy (OIR) modelling human ROP was used to investigate the effect of lutein on retinal vasculature. 13 
METHODS Animals
All the experimental and animal handling procedures were in accordance with the ARVO Statement for the Use 
Mouse model of oxygen-induced retinopathy
Oxygen-induced retinopathy was induced in C57BL/6 mice. Neonatal mice and their nursing dams were exposed to 75% oxygen (PRO-OX110 chamber controller; Biospherix Ltd., New York, NY, USA) from postnatal day 7 (P7) to P12. [13] [14] [15] From P12 to P17, littermate mouse pups were daily intraperitoneally injected with lutein (0.2 mg/kg, Sigma-Aldrich Co, St. Louis, MO) 5 or vehicle 10% dimethyl sulfoxide. On P17, samples were collected and only pups with weight ≥6 g were used. 16 In the other animal group, 0.2 mg/kg lutein or vehicle was injected from P7 to P11, and the samples were collected on P12. During hyperoxic exposure, soda lime served as CO 2 quencher. 16 Mouse pups were limited to 7 to 8 per litter to reduce the runty phenotype. 16 
Central vaso-obliteration and neovascularization
The retinal flat-mounts were permeabilized in 70% ice-cold ethanol for 20 min followed by 1% Triton X-100 PBS for 30 min. The retinae were then stained with Alexa Fluor-488 conjugated isolectin GS-IB4 from Griffonia simplicifolia (0.2 mg/mL; Invitrogen, Carlsbad, CA) overnight at 4°C. 15 The retinal flatmounts were imaged with an upright microscope (Eclipse 80i, Nikon, Tokyo, Japan) under 40× magnification. The vaso-obliterated and total retinal areas were measured using Sigma Scan Pro software (SPSS, Chicago, IL). The percentage of obliterated area over total retinal area was calculated.
Neovascular area was quantified with the tuft area selected by hand in Photoshop CS5 and measured in Image J as reported. 15, 17 The percentage of neovascular area over total retinal area was calculated. In addition, the neovascular tufts invading into the vitreous were also counted on retinal cross sections. 13 Eight sagittal sections (each 30 μm apart) without optic nerve head, four on each side of the optic nerve, were stained with haematoxylin and eosin. Images were taken under 400× magnification.
Vascular leakage: IgG extravasation
The retinal sections with optic nerve head were deparaffinized and incubated with proteinase K. The sections were then reacted with Mouse-On-Mouse biotinylated anti-mouse IgG secondary antibody. IgG immunoreactivity was visualized by incubation with avidin-biotin-peroxidase complex (Vector Laboratories Inc., Burlingame, CA, USA) and the substrate, diaminobenzidine (Invitrogen, Carlsbad, CA, USA). The sections were counterstained with haematoxylin. IgG staining outside blood vessel lumen indicated vascular leakage. 15, 17, 18 Images were taken under 600× magnification.
Assessment of endothelial cell tip cells
Endothelial cell tip cells were visualized on isolectinstained retinal flat-mounts. 19 Images of the boundary between avascular and vascular areas were collected using an upright microscope. The number of endothelial cell tip cells in seven to eight selected 200× fields of view was determined.
Assessment of astrocytic template
The retinal flat-mounts were permeabilized, blocked with 10% goat serum, incubated with rabbit antiglial fibrillary acidic protein (GFAP; 1:200, Dako, Denmark) and isolectin GS-IB4 at 4°C overnight. After three rinses in PBS, the retinal flat-mounts were incubated with Alexa Fluor 568 goat anti-rabbit IgG (1:500; Molecular Probes, Invitrogen, Carlsbad, CA). Six to eight fields were selected in the central avascular zone with similar distance from the optic nerve head. Images were taken with a confocal laser scanning microscope under 200X magnification (LSM700, Carl Zeiss, Thornwood, NY). The extent of astrocyte persistence in the avascular areas was scored on a 1-6 scale as reported. 20 Value 1-2 indicated no or few astrocytes; value 3-4 indicated some astrocytes but these astrocytes lacking standard normal astrocytic template; value 5-6 indicated fairly or completely normal astrocytic template.
Immunohistochemistry for glial cells
The de-paraffinized retinal sections with optic nerve head were blocked with serum and incubated with primary rabbit anti-GFAP (1:500, Dako, Glostrup, Denmark) at 4°C overnight. The retinal sections were then incubated with Alexa Fluor 568 goat anti-rabbit IgG (1:500; Molecular Probes, Invitrogen, Carlsbad, CA) to visualize the signal. Photomicrographs were captured under 400× magnification.
Assessment of retinal microglial responses
The retinal flat-mounts were permeabilized and blocked with 10% goat serum, followed by rabbit anti-Iba-1 (1:800, Wako Chemicals USA, Richmond) and isolectin GS-IB4 for 3 days at 4°C. The retinal flat-mounts were incubated with Alexa Fluor 568 goat anti-rabbit IgG (1:500; Molecular Probes, Invitrogen, Carlsbad, CA). Microglia cells were counted in eight selected 200× fields of confocal images from the avascular area. 15 
Statistical analysis
Data were presented as mean AE SEM. The immunohistochemical investigations were performed in one single experiment. Unpaired t-test, one-way ANOVA and Bonferroni's multiple comparison test were used (Prism v5.0, GraphPad Software Inc., San Diego, CA). Statistically significant difference was set at P < 0.05.
RESULTS

Lutein promoted physiological retinal revascularization
After hyperoxia, vaso-obliteration occurred in vehicle-treated and lutein-treated retinae (Fig. 1a,b) , which became gradually smaller starting from P14 until P17. The avascular area was significantly smaller in the lutein-treated than vehicle-treated retinae (Fig. 1c , n = 6 to 9 mice for each group). Neovasuclar area in flat-mounted retinae (Fig. 1d,e) was measured, and intravitreal neovascular vessels on haematoxylin-and-eosin-stained retinal sections (arrows, Fig. 1g,h ) were quantified. No significant difference in retinal neovascularization was observed between vehicle-treated and lutein-treated OIR mice (Fig. 1f,i , n = 6 to 9 mice for each group).
Lutein reduced retinal blood vascular leakage
The number of leaky blood vessels, which was presented as IgG immunostaining detected outside the blood vessel lumen, 15, 17 was counted in the ganglion cell layer (GCL) and outer plexiform layer (Fig. 2a-d) . Significantly reduced leaky vessels were observed in GCL in lutein-treated versus vehicle-treated OIR retinae (Fig. 2e ,f, n = 5 to 8 mice for each group).
Lutein facilitated endothelial cell tip cell formation in avascular retinae
The facilitated revascularization by lutein in OIR was also investigated by analysing the formation of endothelial cell tip cells, whose filopodia extended from the exiting endothelial cells to the vaso-obliterated area on P14 (Fig. 3a-d) . When comparing the lutein-treated and vehicle-treated OIR mice, significantly increased endothelial cell tip cells were observed in retinae with lutein treatment on P14 (Fig. 3e , n = 7 to 12 for each group).
Lutein preserved astrocytic template in avascular retinae
Astrocytes showed stellate/dendritic morphology and were tightly correlated with the normal retinal vasculature (Fig. 4a,b) . In OIR, the astrocytes lost their normal structure and network (Fig. 4c,d ). In the avascular retinal area, few astrocytes were present in the vehicle-treated retinae (Fig. 4c) , while more astrocytes were observed in lutein-treated retinae (Fig. 4d) . The status of astrocytic template was scored, and an increased score was observed with lutein treament (Fig. 4e , n = 7 to 9 for each group.).
Lutein did not influence glial and microglial cell responses in oxygen-induced retinopathy retinae
Glial fibrillary acidic protein staining was localized in astrocytes around the blood vessels along inner limiting membrane in normal retina (Fig. 5a,b) . In OIR, stronger GFAP immunoreactivity was observed in the astrocytes along inner limiting membrane and in Müller cell processes across inner plexiform layer in lutein-treated and vehicle-treated groups (Fig. 5c,d) .
Microglia undergoes morphological change upon activation. Activated ameboid microglia showed large cell bodies and also expressed isolectin GS-IB4. [21] [22] [23] The non-activated ramified microglia showed small cell bodies with long processes and did not express isolectin GS-IB4. [21] [22] [23] In this study, the microglia status was evaluated in the central retinal area nearby the optic nerve. In the normal retina, inactivated ramified microglia was the major type (arrow, Fig. 6a,b) . In OIR, activated ameboid microglia dominated in the central avascular area (star, Fig. 6c,d ). Ameboid-form microglia was also immuno-positive for isolectin, indicative of activation (star, Fig. 6a-d) . The number of ameboid-form and ramified-form microglia was quantified in the central avascular area. Increased ameboid-form microglia was found in OIR retinae versus normal retinae in both vehicle-treated and lutein-treated groups (Fig. 6e , n = 5 to 9 for each group). However, there was no significant difference between vehicletreated and lutein-treated OIR retinae (Fig. 6e , n = 5 to 9 for each group). No significant changes in the number of inactivated ramified-form microglia were observed between OIR and normal retinae.
Lutein did not prevent hyperoxia-induced retinal vessel loss
The littermate mice were treated with either vehicle or lutein daily from P7 to P11, and the retinas were collected immediately after hyperoxic exposure at P12 (Fig. 7a,b) . No significant differences in central vaso-obliterated area were found between vehicletreated and lutein-treated groups (Fig. 7c , n = 7 to 8 mice for each group) Figure 1 . Lutein promoted the normal vessel regrowth in the central avascular area in oxygen-induced retinopathy (OIR). Flat-mounted retinae were stained with isolectin GS-IB4 for blood vessels (green, a-b). After OIR, a central avascular area was observed (outlined in yellow). (c) Percentage of the central avascular area over the total retinal area at different postnatal days was estimated. Significantly reduced avascular area was observed in the lutein-treated versus vehicle-treated retinae on P14 and P17. In addition, bucketed flatmounted retinae (d-e) and hematoxyline-and-eosin-stained retinal sagittal sections (g-h) were used to analyse neovascularization on P17. No significant difference in neovascular area and number of neovascular tufts was shown between vehicle-treated and luteintreated OIR retinae (f, i). n = 6 to 9 for each group. ***P < 0.001, unpaired t-test. Scale bar, 500 μm (b, e); 25 μm (h). The number of leaky vessels was quantified and expressed as a percentage of total number of retinal vessels (e-f). Significantly reduced retinal leaky vessels in GCL and a trend of decrease in OPL were found in lutein-treated versus vehicle-treated mice. The sections were counterstained with haematoxylin (blue) for nucleus. n = 5 to 8 for each group. *P < 0.05, unpaired t-test. Scale bar, 10 μm.
DISCUSSION
In the present study, central vaso-obliteration, neovascularization, blood vessel leakage and revascularization were observed in the mouse model of OIR as previously reported. 13, 15 We found that lutein in part protected the OIR retinae by facilitating normal retinal vascular regrowth and reducing blood vessel leakage.
Endothelial cell tip cells are essential for the development of new capillaries. Their specialized apical filopodia attach to the astrocytes, which in turn provide the principal cues for guidance of endothelial tip cells and their filopodia. 19, 24 Previously, reduction in endothelial cell tip cells was shown to reduce neovascularization without interfering with intraretinal revascularization in a rat model of ROP. 25 In the mouse model of OIR, revascularization occurs from P12 immediately after hyperoxia. 16 Neovascularization starts from P14 to P17. 16 We here demonstrated that lutein increased endothelial cell tip cells on P14, in line with facilitated intra-retinal revascularization.
In addition, astrocytic changes and Müller cell activation are observed in the animal models of OIR. 13, 15 Astrocytes and Müller cells are two main groups of glial cells in the retina. Retinal astrocytes are involved in the retinal vascular development, Figure 5 . No significant differences were found in Müller cell gliosis between vehicle-treated and lutein-treated oxygen-induced retinopathy (OIR) retinas. Glial fibrillary acidic protein (GFAP) immunoreactivity (red) was observed in astrocytes around the blood vessel lumen in room-air controls (a-b). Increased GFAP immunoreactivity along inner limiting membrane and across inner plexiform layer (IPL) was observed in both OIR groups compared with their room-air controls, respectively (c-d). The sections were counterstained with DAPI (4',6-Diamidino-2-Phenylindole) (blue) for nucleus. (INL, inner nuclear layer; GCL, ganglion cell layer). n = 7 to 9 for each group. Scale bar, 25 μm. In the normal retinae, GFAP-positive astrocytes (red) showed stellate/dendritic morphology and were tightly correlated with the superficial layer of retinal vasculature (isolectin GS-IB4, green). In OIR, the astrocytes lost their normal structure and network in avascular areas. Few astrocytes were present in the vehicle-treated retinae, whereas more astrocytes were observed in lutein-treated retinae. n = 7 to 9 for each group. Scale bar, 50 μm.
forming a template in the superficial vascular layer to facilitate the extension of endothelial cell tip cells. 26 In OIR, astrocytes are lost under hypoxia 20, 27 and maintenance of the astrocytic template normalizes revascularization in OIR. 20 In the present study, lutein treatment in OIR appeared to preserve astrocytic template in the avascular area, corresponding to the facilitated revascularization. Müller cells are specialized glial cells stretching through the entire retina. When activated, Müller cells undergo reactive gliosis, characterized by GFAP up-regulation. 13, 15, 28 Müller cell gliosis contributes to retinal neovascularization and blood-retinal barrier breakdown. 29, 30 Lutein reduces the Müller cell response in ischaemic retina. 31 Here, we found that there were no significant changes in Müller cell gliosis comparing vehicle-treated and lutein-treated OIR mice, corresponding to no change in retinal neovascularization.
Furthermore, microglia, which are resident macrophages to maintain retinal integrity, play an important role in OIR. 15, 22, 32 Upon activation, microglia undergo morphological change from ramified to ameboid form. 15, 22 Promotion of vascular repair by microglia was possibly through hypoxia-inducible factor- Figure 6 . No significant differences were found in microglial activation between vehicle-treated and lutein-treated oxygen-induced retinopathy (OIR) retinas. Representative images of retinal areas stained with Iba-1 antibody (red) and isolectin GS-IB4 (green) on P17. Generally, ramified microglia dominated (arrow, a-b), while occasionally, ameboid microglia (asterisk, a-b) were observed in room-air retinae. In OIR, positive staining with both Iba-1 and isolectin GS-IB4 indicated activated microglia. In the retinal avascular area, ameboid microglia (asterisk, c-d) was significantly increased in superficial vascular layers (e). n = 5 to 9 for each group. *P < 0.05, one-way ANOVA followed by Bonferroni's multiple comparison test. Scale bar, 50 μm. Figure 7 . No significant differences were found in hyperoxia-induced vessel loss at P12. Representative images of retinal whole mount stained with isolectin GS-IB4 (green) on P12. The vaso-obliterated area was outlined in yellow. n = 7 to 8 for each group. Unpaired t-test. Scale bar, 1 mm.
1-alpha in ischaemic retinae. 33 A certain degree of microglial activation in the central avascular retinal area was reported to facilitate revascularization better. 15 Yet there was no significant difference in the number of activated microglia in avascular between lutein-treated and vehicle-treated retinas, indicating that protective effects of lutein on promoting revascularization may not be through microglial modulation.
Taken together, lutein did not have significant impact on the status of Müller cell and microglia in OIR, possibly explaining partially why there were no significant changes in neovascularization as Müller cell gliosis 34 and microglial activation 35, 36 have been suggested to contribute to retinal neovascularization in OIR. The potential mechanism behind the positive effects of lutein on revascularization during the hypoxic phase might be partly due to the increased endothelial cell tip cell formation and the preservation of astrocytic template in central avascular area, which might provide guidance signalling for the normal vessel growth. However, further exploration is needed to determine if lutein has more direct effects on retinal astrocytic preservation and endothelial cell function as there are still limited studies in this field. In addition, photoreceptors are the most metabolically active cell in the body and very susceptible to metabolic derangement and oxidative stress. 37, 38 Dysregulated photoreceptor metabolism triggers pathologic retinal angiogenesis, 39 and the loss of photoreceptors also diminished the mouse oxygen-induced proliferative retinopathy. 40 These observations seemed to indicate that photoreceptor might play a determining role in regulating pathologic retinal vessel growth. Lutein is a strong antioxidant that accumulates in the macula 41 and protects the retinal neurons against oxidative stress-induced apoptosis in vivo and in vitro. 5, 42 We speculate that photoreceptors might also be one of the potential targets in lutein's modulation of retinal vasculature.
As lutein promoted normal vessel growth under hypoxia, we further examined if lutein protected against loss of retinal blood vessels during hyperoxic phase, and no significant differences were found. In human ROP, in addition to the oxygen, the loss of nutrients and maternal growth factors due to the premature birth also contributes to the pathogenesis of the disease progression. 43 Therefore, further studies with respect to the other risk factors are needed before drawing the final conclusion of lutein's efficacy in phase I ROP. For example, hyperglycaemia is recently observed as a novel risk factor for the development of ROP, [44] [45] [46] [47] [48] [49] [50] [51] and hyperglycaemic induction delayed retinal vascular development in neonatal rats. 52 Examining the effects of lutein in the neonatal rodent model of hyperglycaemia-inhibited retinal angiogenesis will help further explore the role of lutein in phase I ROP.
Lutein is one of the carotenoids that can be selectively absorbed by the intestines and accumulated in the macula. 41 Upon ingestion, carotenoids undergo emulsification and micellization for enterocyte absorption. In the enterocyte, carotenoids are packaged into chylomicrons, transported to the liver, repackaged into lipoproteins and transported through the blood. 53 The difference between the routes of intraperitoneal and oral administration is in the absorption phase before entering into the circulation. The drugs are absorbed in the gastrointestinal tract by oral administration and diffused across the peritoneal membrane, which is lined with capillary bed by intraperitoneal injection. Emulsification and micellization of lutein are largely affected by the dietary components; for example, high fat diets increase the bioavailability of lutein in the plasma. 54 Therefore, it would also be worthwhile to consider increasing the bioavailability of lutein through oral administration with supplementation of other lipids like omega-3 long-chain polyunsaturated fatty acids, which are essential in retinal development and inhibits neovascularization in OIR. 55, 56 Clinical trials have reported an ineffective role of lutein in preventing proliferative ROP, while there was a decreasing trend in ROP progression from early ROP to later vision-threatening ROP. [9] [10] [11] The present study demonstrated an effective role of lutein in accelerating revascularization but ineffective in inhibiting the neovascularization in mouse OIR, corresponding to these clinical trial outcomes. In general, our observations indicated that lutein might be considered as a supplement with other ROP treatments through facilitating the normal vascular regrowth, which may help stabilize the functional vasculature in hypoxic retinae and in turn reduce the frequency of treatments for pathologic neovessels.
